what are all the glp-1 drugs to Make of Coverage and Cost Landscape What are GLP-1 Medications and
Description
Obesity is now viewed as a chronic metabolic health problem and not a lifestyle choice
Heartburn and dyspepsia occur in approximately 3-9% of patients taking GLP-1 medications according to clinical trial data
As of now, it is not possible to uncouple the potential benefit of the co-agonists from the additional weight loss
Hall, K
These shifts indicate that while reduced appetite is suppressing demand in some areas, manufacturers capable of addressing emerging consumer needs linked to medication use may uncover new avenues for growth
